Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Cited by (1,011)

Items 601–700 of 1,011

1. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals
   Alexandra M. Johansson, Uma Malhotra, Yeseul G. Kim, Rebecca Gomez, Maxwell P. Krist, Anna Wald, David M. Koelle, William W. Kwok · 2021 · PLoS Pathogens
2. Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
   Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, Achala Kamaladasa, Dinuka Guruge, Ayesha Wijesinghe, Banuri Gunasekera, Shyrar Tanussiya Ramu, Heshan Kuruppu, Thushali Ranasinghe et al. · 2022 · Immunity Inflammation and Disease
3. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
   Dominik Menges, Kyra D. Zens, Tala Ballouz, Nicole Caduff, Daniel Llanas-Cornejo, Hélène Eloise Aschmann, Anja Domenghino, Céline Pellaton, Matthieu Perreau, Craig W. Fenwick et al. · 2022 · Nature Communications
4. Phase 2 Randomized Trial of an AS03 Adjuvanted Plant-Based Virus-Like Particle Vaccine for Covid-19 in Healthy Adults, Older Adults and Adults with Comorbidities
   Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Annie Séguin, Alexander I. Makarkov, Gretchen Heizer, Kapil Bhutada, Asif Mahmood, Nathalie Charland, Sonia Trépanier et al. · 2021 · medRxiv
5. Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2
   Kanako Shimizu, Tomonori Iyoda, An Sanpei, Hiroshi Nakazato, Masahiro Okada, Shogo Ueda, M. Kato-Murayama, Kazutaka Murayama, Mikako Shirouzu, Naoko Harada et al. · 2021 · Communications Biology
6. Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected
   Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Claudia Monari, Barbara Luciani Pasqua, Filippo Dragoni, Elisabetta Schiaroli, Maurizio Zazzi et al. · 2021 · Journal of Infection
7. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
   Margherita Rosati, Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, Mahesh Agarwal, Jenifer Bear, Robert T Burns, Xintao Hu, Eleni Korompoki, Duncan E. Donohue, David J. Venzon et al. · 2021 · Frontiers in Immunology
8. Immune Imprinting and Implications for COVID-19
   Zhiqian Zhou, Julia Barrett, Xuan He · 2023 · Vaccines
9. The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
   Linda Petrone, Alessandro Sette, Rory D. de Vries, Delia Goletti · 2023 · Pathogens
10. Applications of time series analysis in epidemiology: Literature review and our experience during COVID-19 pandemic
    L Tomov, Lyubomir Chervenkov, Dimitrina Miteva, Hristiana Batselova, Tsvetelina Veselinova Velikova · 2023 · World Journal of Clinical Cases
11. Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies
    Aodhán Seán Breathnach, Christopher James Arthur Duncan, Kate El Bouzidi, Aidan T. Hanrath, Brendan A. I. Payne, Paul Anthony Randell, Maximillian S. Habibi, Peter Andrew Riley, Tim Planche, John Busby et al. · 2021 · Journal of Infection
12. Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2
    Maya F. Amjadi, Sarah E. O’Connell, Tammy Armbrust, Aisha M. Mergaert, Sandeep Narpala, Peter Halfmann, S. Janna Bashar, Christopher R. Glover, Anna S. Heffron, Alison Taylor et al. · 2021 · ImmunoHorizons
13. Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail
    Arnaud C. Drouin, Marc Theberge, Sharon Y. Liu, Allison R. Smither, Shelby Flaherty, Mark Zeller, Gregory P. Geba, Peter Reynaud, W. Benjamin Rothwell, Alfred Luk et al. · 2021 · Viruses
14. Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
    Sasha E. Larsen, Bryan J. Berube, Tiffany Pecor, Evan Cross, Bryan P. Brown, Brittany D. Williams, Emma Johnson, Pingping Qu, Lauren P. Carter, Samuel P. Wrenn et al. · 2021 · Journal of Immunological Methods
15. SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease
    Raphael A. Reyes, Kathleen Clarke, S. Jake Gonzales, Angelene M. Cantwell, Rolando Garza, Gabriel Catano, Robin E. Tragus, Thomas F. Patterson, Sebastiaan M. Bol, Evelien M. Bunnik · 2021 · PLoS ONE
16. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
    Shihan Zhang, Ke Xu, Chu-Chu Li, Lu Zhou, Xiaoxiao Kong, Jiefu Peng, F. Zhu, C. Bao, Hui Jin, Qiang Gao et al. · 2022 · Frontiers in Immunology
17. Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug
    Bo Zhang, Junjie Tian, Qintao Zhang, Yan Xie, Kejia Wang, Shuyi Qiu, Keyu Lu, Yang Liu · 2022 · Frontiers in Molecular Biosciences
18. PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2
    Viviana R. Simon, Vamsi K Kota, Ryan F. Bloomquist, Hannah B. Hanley, David Forgacs, Savita G. Pahwa, Suresh Pallikkuth, Loren Gregory Miller, Joanna M. D. Schaenman, Michael R. Yeaman et al. · 2022 · mSphere
19. Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
    Dorota Kamińska, Dominika Dęborska−Materkowska, Katarzyna Kościelska−Kasprzak, Oktawia Mazanowska, Agata Remiorz, Paweł Poznański, Magdalena Durlik, Magdalena Krajewska · 2022 · Vaccines
20. Serum‐derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID‐19 patients
    Tobias Tertel, Sergej Tomić, Jelena Đokić, Dušan Radojević, Dejan Stevanović, Nataša Ilić, Bernd Giebel, Maja Kosanović · 2022 · Journal of Extracellular Vesicles
21. Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2
    Jorge Hernández‐Bello, José Javier Morales‐Núñez, Andrea Carolina Machado-Sulbarán, Saúl Alberto Díaz-Pérez, Paola Carolina Torres-Hernández, Paulina Balcázar-Félix, Jesús Alberto Gutiérrez-Brito, José Álvaro Lomelí-Nieto, José Francisco Muñóz-Valle · 2021 · Vaccines
22. Effectiveness of COVID‑19 vaccines and their challenges (Review)
    Gabriella Marfè, Stefania Perna, Arvind Kumar Shukla · 2021 · Experimental and Therapeutic Medicine
23. Is There an Inflammatory Profile of Perinatal Depression?
    Clare A. McCormack, Sameera Abuaish, Catherine E. Monk · 2023 · Current Psychiatry Reports
24. Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses
    Houssein H. Ayoub, Hiam S. Chemaitelly, Monia Makhoul, Zaina Al Kanaani, Einas Al‐Kuwari, Adeel Ajwad Butt, Peter Valentine Coyle, Andrew M. Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif et al. · 2021 · BMJ Innovations
25. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors
    Chunhua Luo, Min Liu, Qianyuan Li, Xiaoling Zheng, Wen Ai, Feng Gong, Jinhong Fan, Shaowei Liu, Xi Wang, Jun Luo · 2021 · International Journal of Infectious Diseases
26. kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers
    José Felipe Varona, Rodrigo Madurga, Francisco J. Peñalver, Elena Abarca, Cristina Almirall, Marta Cruz, Enrique Ramos, Jose María Castellano-Vazquez · 2021 · European Journal of Internal Medicine
27. Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
    Emanuele Amodio, Giuseppina Capra, Alessandra Casuccio, Simona De Grazia, Dario Genovese, Stefano Pizzo, Giuseppe Calamusa, Donatella Ferraro, Anna Giammanco, Francesco Maria Vitale et al. · 2021 · Vaccines
28. Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months
    Louise J. Robertson, Julie S. Moore, Kevin Blighe, Kok Yew Ng, Nigel Quinn, Fergal Jennings, Gary Warnock, Peter C. Sharpe, Mark Clarke, Kathryn Maguire et al. · 2021 · BMJ Open
29. The Role of Serology Testing to Strengthen Vaccination Initiatives and Policies for COVID-19 in Europe
    Paolo Bonanni, Rafael Cantón, Dipender Gill, Philippe Halfon, Uwe G. Liebert, Katya A. Nogales Crespo, Jaime Jesús Pérez Martín, Claudia Maria Trombetta · 2021 · COVID
30. Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
    A. Wagner, A. Guzek, J. Ruff, J. Jasińska, U. Scheikl, I. Zwazl, M. Kundi, H. Stockinger, Maria R. Farcet, T. Kreil et al. · 2021 · Communications Medicine
31. Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective
    Jeremy Baldwin, Sakshi Piplani, Isaac G. Sakala, Yoshikazu Honda‐Okubo, Lei Li, Nikolai Petrovsky · 2021 · Bioanalysis
32. Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
    Luísa Canto e Castro, Andréia Gomes, Marta Serrano, Ana Helena Guia Pereira, Rita Ribeiro, Patrícia Napoleão, Inês Domingues, Cláudia Silva, Júlia Fanczal, Ângela Afonso et al. · 2021 · European Journal of Immunology
33. Incidence of COVID-19 reinfection among Midwestern healthcare employees
    Anne L. Rivelli, Veronica Fitzpatrick, Christopher Blair, Kenneth Copeland, Jon Richards · 2022 · PLoS ONE
34. Post-vaccination T cell immunity to omicron
    Henning Jacobsen, Viviana Cobos Jiménez, Ioannis Sitaras, Naor Bar‐Zeev, Luka Čičin‐Šain, Melissa M. Higdon, Maria Deloria Knoll · 2022 · Frontiers in Immunology
35. SARS CoV-2 infections in animals, two years into the pandemic
    Sara Frazzini, Massimo Amadori, Lauretta Turin, Federica Riva · 2022 · Archives of Virology
36. SARS -CoV-2 T-cell immunity to variants of concern following vaccination
    Kathleen Gallagher, Mark B. Leick, Rebecca C. Larson, Trisha R. Berger, Katelin Katsis, Jennifer Y. Yam, Gabrielle Brini, Korneel Grauwet, MGH COVID-19 Collection & Processing Team, Marcela Valderrama Maus · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
37. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid organ transplant recipients
    Peter G. Stock, Timothy J. Henrich, Dorry Lidor Segev, William A. Werbel · 2021 · Journal of Clinical Investigation
38. Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine
    Davide Ferrari, Nicola Clementi, Elena Criscuolo, Alessandro Ambrosi, Francesca Corea, Chiara Di Resta, Rossella Tomaiuolo, Nicasio Mancini, Massimo Locatelli, Mario Plebani et al. · 2021 · Vaccines
39. Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
    Abhinay Gontu, Sreenidhi Srinivasan, Eric Salazar, Meera Surendran Nair, Ruth Helmus Nissly, Denver I. Greenawalt, Ian M. Bird, Catherine M. Herzog, Matthew Joseph Ferrari, Indira B. Poojary et al. · 2021 · Communications Biology
40. Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China
    Monia Makhoul, Hiam S. Chemaitelly, Houssein H. Ayoub, Shaheen Seedat, Laith Jamal Abu-Raddad · 2021 · Vaccines
41. Biobehavioral Aspects of the COVID-19 Pandemic: A Review
    Peter A. Hall, Paschal Sheeran, Geoffrey T. Fong, Charissa S. L. Cheah, Mark Oremus, Teresa Y L Liu-Ambrose, Mohammad Nazmus Sakib, Zahid A Butt, Hasan Ayaz, Narveen Jandu et al. · 2021 · Psychosomatic Medicine
42. Functional responsiveness of memory T cells from COVID-19 patients
    Ece Tavukçuoğlu, Utku Horzum, Ahmet Çağkan İnkaya, Serhat Ünal, Güneş Esendağlı · 2021 · Cellular Immunology
43. The BNT162b2 vaccine is associated with lower new COVID ‐19 cases in nursing home residents and staff
    Marsida Domi, Michael Leitson, David R Gifford, Anna Nicolaou, Kiran Sreenivas, Courtney Bishnoi · 2021 · Journal of the American Geriatrics Society
44. Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
    Lorena Vigón, Javier García‐Pérez, Sara Rodríguez-Mora, Montserrat Torres, Elena Mateos, María Castillo de la Osa, Miguel Cervero, Rosa Malo de Molina, Cristina Navarro, María Aránzazu Murciano-Antón et al. · 2021 · Frontiers in Immunology
45. Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh
    Afroza Akter, Tasnuva Ahmed, Imam Tauheed, Marjahan Akhtar, Sadia Isfat Ara Rahman, Fatema Khaton, Faisal Ahmmed, Jannatul Ferdous, Mokibul Hassan Afrad, Zannat Kawser et al. · 2022 · PLoS neglected tropical diseases
46. Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
    Edwards Pradenas, Benjamin Trinité, Víctor Urrea, Sílvia Marfil, Ferran Tarrés-Freixas, Raquel Ortiz, Carla Rovirosa, Jordi Rodon, Júlia Vergara‐Alert, Joaquím Segalés et al. · 2022 · Cell Reports Medicine
47. Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
    Ellie Taus, Christian Hofmann, Francisco Javier Ibarrondo, Mary Ann Hausner, Jennifer A. Fulcher, Paul A Krogstad, Kathie G. Ferbas, Nicole H. Tobin, Anne W. Rimoin, Grace M. Aldrovandi et al. · 2022 · Frontiers in Immunology
48. SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies
    Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Jessica E. Davies, Monika Patel, Robin Gopal, Luke Muir, Felicity Aiano, Katie J. Doores et al. · 2022 · DOAJ (DOAJ: Directory of Open Access Journals)
49. Persistence of Functional Memory B Cells Recognizing SARS-CoV-2 Variants Despite Loss of Specific IgG
    Stephan Winklmeier, Katharina Eisenhut, Damla Taskin, Heike Rübsamen, Ramona Gerhards, Celine Schneider, Paul R. Wratil, Marcel Stern, Peter Eichhorn, Oliver Till Keppler et al. · 2021 · iScience
50. Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults
    Lior Rennert, Zichen Ma, Christopher S. McMahan, Delphine Dean · 2022 · Nature Communications
51. Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
    Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, Achala Kamaladasa, Dinuka Guruge, Ayesha Wijesinghe, Banuri Gunasekera, Shyrar Tanussiya, Heshan Kuruppu, Thushali Ranasinghe et al. · 2021 · medRxiv
52. Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy
    Thomas Gastinne, Amandine Le Bourgeois, Marianne Coste‐Burel, Thierry Guillaume, Pierre Péterlin, Alice Garnier, Berthe‐Marie Imbert, Thomas Drumel, Beatrice Mahé, Viviane Dubruille et al. · 2021 · British Journal of Haematology
53. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
    Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, Kristen M. Valentine, Paolla Beatriz Almeida Pinto, Andrew Gonzalez, José Ángel Regla-Nava, Erin Maule, Michael N. Nguyen, Norazizah Shafee et al. · 2024 · Nature Communications
54. Update on inborn errors of immunity
    Hanna IJspeert, Emily S.J. Edwards, Robyn E. O’Hehir, Virgil A. S. H. Dalm, Menno C. van Zelm · 2024 · Journal of Allergy and Clinical Immunology
55. Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination
    Vivien Karl, Maike Hofmann, Robert Thimme · 2025 · Journal of Virology
56. Multiple Levels of Immunological Memory and Their Association with Vaccination
    Zsófia Bugya, József Prechl, Tibor Szénási, Éva Nemes, Attila Bácsi, Gábor Koncz · 2021 · Vaccines
57. Long-Term Regulation of Prolonged Epidemic Outbreaks in Large Populations via Adaptive Control: A Singular Perturbation Approach
    M. Ali Al-Radhawi, Mahdiar Sadeghi, Eduardo D. Sontag · 2021 · IEEE Control Systems Letters
58. Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection
    Rohan Ameratunga, See‐Tarn Woon, Anthony Jordan, Hilary J Longhurst, Euphemia Yee Leung, Richard Henderson Steele, Klaus Lehnert, Russell G. Snell, Anna E. S. Brooks · 2021 · Expert Review of Clinical Immunology
59. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study
    Philipp P. Kohler, Sabine Güsewell, Marco Seneghini, Thomas Egger, Onicio Batista Leal-Neto, Angela Brucher, Eva Lemmenmeier, Jens Carsten Möller, Philip Rieder, Markus Ruetti et al. · 2021 · BMC Medicine
60. Detection of IFNγ-Secreting CD4+ and CD8+ Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2
    Victoria Matyushenko, Исакова-Сивак Ирина Николаевна, Igor Vladimirovich Kudryavtsev, Arina Goshina, Anna K. Chistyakova, Ekaterina Stepanova, Прокопенко Полина Игоревна, Ivan А. Sychev, Руденко Лариса Георгиевна · 2021 · Viruses
61. Longitudinal analysis of antibody decay in convalescent COVID-19 patients
    Weiming Xia, Mingfei Li, Ying Wang, Lewis E. Kazis, Kim Berlo, Noureddine Melikechi, Gregory R. Chiklis · 2021 · Scientific Reports
62. Immunity Profiling of COVID-19 Infection, Dynamic Variations of Lymphocyte Subsets, a Comparative Analysis on Four Different Groups
    Mario Giosuè Balzanelli, Pietro Distratis, Gianna Dipalma, Luigi Vimercati, Orazio Catucci, Felice Amatulli, Angelo Cefalo, Rita Lazzaro, Davide Palazzo, Sergey Khachatur Aityan et al. · 2021 · Microorganisms
63. Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
    Laura T. Gray, Michal M. Raczy, Priscilla S. Briquez, Tiffany M. Marchell, Aaron T. Alpar, Rachel P. Wallace, Lisa R. Volpatti, Maria Stella Sasso, Shijie Cao, Mindy Nguyen et al. · 2021 · Biomaterials
64. Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals
    Nuria Tormo, David Navalpotro, María Martínez-Serrano, Marta Moreno, Fernando Grosson, Irene Tur, Maria Remedios Guna, Pepa Soriano, Ana Tornero, Concepción Gimeno · 2021 · Diagnostic Microbiology and Infectious Disease
65. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2
    Hidetsugu Fujigaki, Yasuko Yamamoto, Takenao Koseki, Sumi Banno, Tatsuya Ando, Hiroyasu Ito, Takashi Fujita, Hiroyuki Naruse, Tadayoshi Hata, Saya Moriyama et al. · 2022 · Microbiology Spectrum
66. Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
    Lu Lu, Lin‐Lei Chen, Ruiqi Zhang, Owen Tak‐Yin Tsang, Jacky Man‐Chun Chan, Anthony Raymond Tam, Wai-Shing Leung, Thomas Shiu‐Hong Chik, Daphne Pui-Ling Lau, Chris Yau-Chung Choi et al. · 2022 · EBioMedicine
67. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19
    Maik Pietzner, Robert Lorenz Chua, Eleanor Wheeler, Katharina Jechow, Julian Willett, Helena Radbruch, Saskia Trump, Bettina Heidecker, Hugo Zeberg, Frank L. Heppner et al. · 2022 · Nature Communications
68. High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection
    Eva‐Maria Jacobsen, Dorit Fabricius, Magdalena Class, Fernando Topfstedt, Raquel Lorenzetti, Iga Janowska, Franziska Schmidt, Julian Staniek, Maria Zernickel, Thomas Stamminger et al. · 2022 · Nature Communications
69. Identification of key genes associated with persistent immune changes and secondary immune activation responses induced by influenza vaccination after COVID-19 recovery by machine learning methods
    Jingxin Ren, Xianchao Zhou, Ke Qiang Huang, Lei Chen, Wei Guo, Kaiyan Feng, Tao Huang, Yu‐Dong Cai · 2023 · Computers in Biology and Medicine
70. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature
    Stéphane Derruau, Jérôme Bouchet, Ali Nassif, Alexandre Baudet, Kazutoyo Yasukawa, Sandrine Lorimier, Isabelle Prêcheur, Agnès Bloch‐Zupan, B. Pellat, Hélène Chardin et al. · 2021 · Journal of Clinical Medicine
71. Ethics of selective restriction of liberty in a pandemic
    James Cameron, Bridget M Williams, Romain R. Ragonnet, Ben J. Marais, James McCracken Trauer, Julian Savulescu · 2021 · Journal of Medical Ethics
72. COVID-19 Research: Lessons from Non-Human Primate Models
    Laure Albrecht, Elodie Bishop, Basile Jay, Blaise Lafoux, Marie Minoves, Caroline Passaes · 2021 · Vaccines
73. Interleukin-21 in Viral Infections
    H. Asao · 2021 · International Journal of Molecular Sciences
74. SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination
    Yudi Tatiana Pinilla, Constanze Heinzel, Lena-Fabienne Caminada, Douglas Consolaro, Meral Esen, Peter G. Kremsner, Jana Held, Andrea Kreidenweiss, Rolf Fendel · 2021 · Frontiers in Immunology
75. Exercise as a Moderator of Persistent Neuroendocrine Symptoms of COVID-19
    Candida Joan Rebello, Christopher L. Axelrod, Charles F. Reynolds, Frank L. Greenway, John P. Kirwan · 2022 · Exercise and Sport Sciences Reviews
76. Neutralizing antibody: a savior in the Covid-19 disease
    Sneh Lata Gupta, Rishi Kumar Jaiswal · 2022 · Molecular Biology Reports
77. scINSIGHT for interpreting single-cell gene expression from biologically heterogeneous data
    Kun Qian, Shiwei Fu, Hongwei Li, Wei Vivian Li · 2022 · Genome biology
78. A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
    Shobha Upreti, Mukesh Samant · 2022 · Pharmaceutical Research
79. Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers
    Fotinie Ntziora, Evangelia Georgia Kostaki, Αmalia Karapanou, Maria Mylona, Ioulia K. Tseti, Nikolaos V. Sipsas, Dimitrios N. Paraskevis, Petros Paul Sfikakis · 2022 · Vaccine
80. Humoral and cellular immune responses to CoronaVac up to one year after vaccination
    Priscilla R. Costa, Carolina Argondizo Correia, Mariana Prado Marmorato, Juliana Zanatta de Carvalho Dias, Mateus Vailant Thomazella, Amanda Cabral da Silva, Ana Carolina Soares de Oliveira, Arianne Fagotti Gusmão, Lílian Pereira Ferrari, Ângela Carvalho Freitas et al. · 2022 · Frontiers in Immunology
81. The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence
    Anna Paola Capra, Alessio Ardizzone, Giuseppe Pantò, Irene Paterniti, Michela Campolo, Lelio Crupi, Raffaele Squeri, Emanuela Esposito · 2023 · International Journal of Molecular Sciences
82. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
    Aljawharah Alrubayyi, Ester Gea‐Mallorquí, Emma Touizer, Dan Hameiri‐Bowen, Jakub T. Kopycinski, Bethany G. Charlton, Natasha Fisher-Pearson, Luke Muir, Annachiara Rosa, Chloë Roustan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
83. Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses
    Eric D. Laing, Spencer L. Sterling, Stephanie A Richard, Nusrat J Epsi, Si’Ana A. Coggins, Emily C Samuels, Shreshta Phogat, Lianying Yan, Nicole Moreno, Christian L. Coles et al. · 2021 · medRxiv
84. mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infection
    Ellie N. Ivanova, Jasmine Shwetar, Joseph Cooper Devlin, Terkild B. Buus, Sophie L. Gray-Gaillard, Akiko Koide, Amber R. Cornelius, Marie I. Samanovic, Alberto M. Herrera, Eleni P. Mimitou et al. · 2021 · medRxiv
85. Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
    Günl, Franziska, Mecate-Zambrano, Angeles, Rehländer, Selina, Hinse, Saskia, Ludwig, Stephan, Brunotte, Linda · 2021 · Vaccines
86. Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
    Graham, Carl, Seow, Jeffrey, Huettner, Isabella, Khan, Hataf, Kouphou, Neophytos, Acors, Sam, Winstone, Helena, Pickering, Suzanne, Galao, Rui Pedro, Lista, Maria Jose et al. · 2021
87. Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection
    Pyoeng Gyun Choe, Chang Kyung Kang, Kye‐Hyung Kim, Jongyoun Yi, Eu Suk Kim, San Won Park, Nam Joong Kim, Wan Beom Park, Myoung‐don Oh · 2021 · The Journal of Infectious Diseases
88. SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods
    Elitza S. Theel, Patrick W. Johnson, Katie L. Kunze, Liang Li Wu, Amy P. Gorsh, Dane Granger, Matthew M. Roforth, Calvin R. Jerde, Michael A. Lasho, Kylie J. Andersen et al. · 2021 · Journal of Clinical Microbiology
89. Immune activation and immune-associated neurotoxicity in Long-COVID: A systematic review and meta-analysis of 103 studies comprising 58 cytokines/chemokines/growth factors
    Abbas Firras Almulla, Yanin Thipakorn, Bo Zhou, Aristo Vojdani, Michael H. J. Maes · 2024 · Brain Behavior and Immunity
90. Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
    Kirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, Lutz Gieselmann, Kanika Vanshylla, Maike Wirtz, Franziska Kleipass, Wibke Johannis, Philipp Schommers, Henning Gruell et al. · 2021 · Microorganisms
91. A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients
    Yi-Qi R. Luo, C. Yun, I. Chakraborty, A. Wu, K. Lynch · 2021 · Journal of Clinical Microbiology
92. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
    Pankaj Kumar Ahluwalia, Kumar Vaibhav, Meenakshi Ahluwalia, Ashis Kumar Mondal, Nikhil Sahajpal, Amyn M. Rojiani, Ravindra B Kolhe · 2021 · Frontiers in Immunology
93. IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers
    Rianna Vandergaast, Timothy S. Carey, Samantha Reiter, Chase Lathrum, Patrycja J. Lech, Clement W. Gnanadurai, Michelle Haselton, Jason Buehler, Riya Narjari, Luke Schnebeck et al. · 2021 · mSphere
94. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
    Elisa Petruccioli, Saeid Najafi Fard, Assunta Navarra, Linda Petrone, Valentina Vanini, Gilda Cuzzi, Gina Gualano, Luca Pierelli, Antonio Bertoletti, Emanuele Nicastri et al. · 2021 · Journal of Translational Medicine
95. Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids
    Paolo Cattaneo, Alessandro Volpe, Chiara Simona Cardellino, Niccolò Riccardi, Giulia Bertoli, Tamara Ursini, Arjola Ustalli, Giovanni Lodi, Ivan Daroui, Andrea Angheben · 2021 · Microorganisms
96. Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects
    Eleonora Gallerani, Davide Proietto, Beatrice Dallan, Marco Campagnaro, Salvatore Pacifico, Valentina Albanese, Erika Marzola, Peggy Marconi, Antonella Caputo, Victor Appay et al. · 2021 · Frontiers in Immunology
97. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days
    Sergio Gil-Manso, Diego Carbonell, Luis Andrés López-Fernández, Iría Miguens, Roberto Alonso, Ismael Buño, Patricia Muñóz, Jordi Ochando, Marjorie Pion, Rafael Correa‐Rocha · 2021 · Frontiers in Immunology
98. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing
    Irene Maeve Rea, H. Denis Alexander · 2021 · Ageing Research Reviews
99. Humoral and cellular immune responses to the SARS‐CoV‐2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls
    Ahmad Yanis, Zaid Haddadin, Andrew J. Spieker, Danya Waqfi, Danielle A. Rankin, Rana Talj, Lora D. Thomas, Kelly A. Birdwell, Lauren J Ezzell, Marcia A. Blair et al. · 2021 · Transplant Infectious Disease
100. Characterization of memory T cell subsets and common γ−chain cytokines in convalescent COVID-19 individuals
     Anuradha Rajamanickam, Nathella Pavan Kumar, Arul Nancy Pandiaraj, Nandhini Selvaraj, Saravanan Munisankar, Rachel Mariam Renji, Vijayalakshmi Venkataramani, Manoj Murhekar, Jeromie Wesley Vivian Thangaraj, Santhosh Kumar Muthusamy et al. · 2022 · Journal of Leukocyte Biology